Built for PSX investors
Follow live PSX prices, track holdings, read business news, and keep your watchlist close before the market moves.

ABOTAbbott Laboratories LtdAbbott Laboratories (Pakistan) Limited announced board-approved un-audited financial results for the quarter ended March 31, 2026. Net sales increased to Rs 17.705 billion, gross profit rose to Rs 6.698 billion, operating profit improved to Rs 3.309 billion, and net profit increased to Rs 1.940 billion versus Rs 1.600 billion in the same quarter last year. EPS rose to Rs 19.82 from Rs 16.34. Cash and bank balances remained strong at Rs 12.473 billion as of March 31, 2026.
| Metric | PreviousJan-Mar 2025 | CurrentJan-Mar 2026 | Change |
|---|---|---|---|
| Sales - net | 17,346,451 | 17,704,722 | +2.1% |
| Gross profit | 5,841,906 | 6,697,808 | +14.7% |
| Operating profit | 2,755,859 | 3,308,709 | +20.1% |
| Net profit for the period | 1,599,673 | 1,940,308 | +21.3% |
| Basic and diluted earnings per share | 16.34 | 19.82 | +21.3% |
| Finance costs | 3,947 | 18,153 | +359.9% |
| Cash and bank balances | 13,337,551 | 12,473,406 | -6.5% |
Highlights summarize the key points from the company's official PSX filing. View the original filing for the complete details before making financial decisions.
Get Investify
The information on Investify is for informational purposes only and is not financial, investment, legal or tax advice. Market data, announcements, news, highlights, Buy/Sell/Neutral labels and other values may be sourced from or relate to Recube Technologies LLP, third-party providers and automated systems; none of these parties guarantees the timeliness, accuracy, completeness, correct sequencing, reliability or availability of such information. Nothing on the website or app is an offer, solicitation, recommendation or advice to buy, sell, hold or enter into any transaction. Investing involves risk, and users are responsible for verifying original sources and consulting qualified advisers before making investment decisions.
© 2026 Investify. All rights reserved.